Extract

The primary purpose of this study is to obtain long-term safety data with CZP in patients with Rheumatoid Arthritis (RA). Additional objectives are to assess the dose and type of Arthritis medication(s) utilized by patients, and to assess the long-term impact of CZP on physical function. Treatment will continue up to approval of a marketing application for this product.

Inclusion criteria

• Rheumatoid Arthritis

Country

• Austria
• Belgium
• Czech Republic
• Germany
• Ireland
• United Kingdom
• United States

Links

• nct
• ictrp